AI-Informed Platform "AdaptiveFlow" Accelerates Drug Discovery with 1,000-Fold Cost Reduction

Researchers from St. Jude Children's Research Hospital have unveiled AdaptiveFlow, an AI-informed platform published in Nature Biotechnology, capable of virtually screening billions of drug-like molecules with a 1,000-fold reduction in computational costs, setting a new benchmark for cloud-based drug discovery.